Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors

被引:2
作者
Lee, Min Kyung [1 ]
Zhang, Ze [1 ]
Sehgal, Kartik [2 ]
Butler, Rondi [3 ,4 ]
Stolrow, Hannah [1 ]
Ramush, Geat [3 ,4 ]
Shirai, Keisuke [5 ]
Koestler, Devin C. [6 ]
Salas, Lucas A. [1 ]
Wiencke, John K. [7 ]
Haddad, Robert [2 ]
Kelsey, Karl T. [3 ,4 ]
Christensen, Brock C. [1 ,8 ,9 ]
机构
[1] Geisel Sch Med Dartmouth, Dept Epidemiol, Lebanon, NH 03755 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[3] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02903 USA
[4] Brown Univ, Dept Pathol & Lab Med, Sch Med, Providence, RI 02903 USA
[5] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA
[6] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Kansas City, KS 66103 USA
[7] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[8] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH 03755 USA
[9] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH 03755 USA
基金
美国国家卫生研究院;
关键词
DNA methylation; head and neck squamous cell carcinoma; immune checkpoint inhibitors; immune profiles; immunomethylomics; methylation cytometry; MEMORY T-CELLS; DNA METHYLATION;
D O I
10.1080/17501911.2024.2343274
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: This study addresses the challenge of predicting the response of head and neck squamous cell carcinoma (HNSCC) patients to immunotherapy. Methods: Using DNA methylation cytometry, we analyzed the immune profiles of six HNSCC patients who showed a positive response to immunotherapy over a year without disease progression. Results: There was an initial increase in CD8 T memory cells and natural killer cells during the first four cycles of immunotherapy, which then returned to baseline levels after a year. Baseline CD8 T cell levels were lower in HNSCC immunotherapy responders but became similar to those in healthy subjects after immunotherapy. Conclusion: These findings suggest that monitoring fluctuations in immune profiles could potentially identify biomarkers for immunotherapy response in HNSCC patients.
引用
收藏
页码:799 / 807
页数:9
相关论文
共 37 条
[1]   Biplots of compositional data [J].
Aitchison, J ;
Greenacre, M .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2002, 51 :375-392
[2]   Risk of Malignant Transformation in 3173 Subjects with Histopathologically Confirmed Oral Lichen Planus: A 33-Year Cohort Study in Northern Italy [J].
Arduino, Paolo G. ;
Magliano, Alessandro ;
Gambino, Alessio ;
Macciotta, Alessandra ;
Carbone, Mario ;
Conrotto, Davide ;
Karimi, Dora ;
Carrozzo, Marco ;
Broccoletti, Roberto .
CANCERS, 2021, 13 (22)
[3]   Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays [J].
Aryee, Martin J. ;
Jaffe, Andrew E. ;
Corrada-Bravo, Hector ;
Ladd-Acosta, Christine ;
Feinberg, Andrew P. ;
Hansen, Kasper D. ;
Irizarry, Rafael A. .
BIOINFORMATICS, 2014, 30 (10) :1363-1369
[4]   Biological and methodological variation of lymphocyte subsets in blood of human adults [J].
Backteman, Karin ;
Ernerudh, Jan .
JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 322 (1-2) :20-27
[5]   Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes [J].
Chen, Ji-Qing ;
Salas, Lucas A. ;
Wiencke, John K. ;
Koestler, Devin C. ;
Molinaro, Annette M. ;
Andrew, Angeline S. ;
Seigne, John D. ;
Karagas, Margaret R. ;
Kelsey, Karl T. ;
Christensen, Brock C. .
CLINICAL EPIGENETICS, 2022, 14 (01)
[6]   Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study [J].
Cohen, Ezra E. W. ;
Soulieres, Denis ;
Le Tourneau, Christophe ;
Dinis, Jose ;
Licitra, Lisa ;
Ahn, Myung-Ju ;
Soria, Ainara ;
Machiels, Jean-Pascal ;
Mach, Nicolas ;
Mehra, Ranee ;
Burtness, Barbara ;
Zhang, Pingye ;
Cheng, Jonathan ;
Swaby, Ramona F. ;
Harrington, Kevin J. .
LANCET, 2019, 393 (10167) :156-167
[7]   Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma [J].
de Coana, Yago Pico ;
Wolodarski, Maria ;
Poschke, Isabel ;
Yoshimoto, Yuya ;
Yang, Yuan ;
Nystrom, Maria ;
Edback, Ulrika ;
Brage, Suzanne Eghyazi ;
Lundqvist, Andreas ;
Masucci, Giuseppe V. ;
Hansson, Johan ;
Kiessling, Rolf .
ONCOTARGET, 2017, 8 (13) :21539-21553
[8]  
Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x
[9]   The consecutive disparity index, D: a measure of temporal variability in ecological studies [J].
Fernandez-Martinez, Marcos ;
Vicca, Sara ;
Janssens, Ivan A. ;
Carnicer, Jofre ;
Martin-Vide, Javier ;
Penuelas, Josep .
ECOSPHERE, 2018, 9 (12)
[10]   Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck [J].
Ferris, R. L. ;
Blumenschein, G., Jr. ;
Fayette, J. ;
Guigay, J. ;
Colevas, A. D. ;
Licitra, L. ;
Harrington, K. ;
Kasper, S. ;
Vokes, E. E. ;
Even, C. ;
Worden, F. ;
Saba, N. F. ;
Iglesias Docampo, L. C. ;
Haddad, R. ;
Rordorf, T. ;
Kiyota, N. ;
Tahara, M. ;
Monga, M. ;
Lynch, M. ;
Geese, W. J. ;
Kopit, J. ;
Shaw, J. W. ;
Gillison, M. L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1856-1867